Via the European Decentralized Procedure (Netherlands is the Reference Member State), Apricus...

|About: Apricus Biosciences, Inc (APRI)|By:, SA News Editor

Via the European Decentralized Procedure (Netherlands is the Reference Member State), Apricus (APRI) gets its ED treatment Vitaros approved. The company believes it will "capture a significant share of the ~$1B PDE-5 inhibitor market." APRI says it will work with partners Sandoz, Takeda (TKPHF.PK), and Bracco to obtain national phase approvals. Shares +9.38% premarket. (PR)